Riggs Asset Management’s Marker Therapeutics MRKR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.84K | Hold |
1,200
| – | – | ﹤0.01% | 668 |
|
|
2025
Q1 | $1.48K | Hold |
1,200
| – | – | ﹤0.01% | 428 |
|
|
2024
Q4 | $4.01K | Hold |
1,200
| – | – | ﹤0.01% | 312 |
|
|
2024
Q3 | $3.38K | Sell |
1,200
-200
| -14% | -$564 | ﹤0.01% | 323 |
|
|
2024
Q2 | $7.6K | Hold |
1,400
| – | – | ﹤0.01% | 272 |
|
|
2024
Q1 | $6.02K | Sell |
1,400
-200
| -13% | -$860 | ﹤0.01% | 272 |
|
|
2023
Q4 | $8.8K | Sell |
1,600
-750
| -32% | -$4.13K | ﹤0.01% | 254 |
|
|
2023
Q3 | $10.7K | Sell |
2,350
-200
| -8% | -$908 | ﹤0.01% | 236 |
|
|
2023
Q2 | $7.91K | Hold |
2,550
| – | – | ﹤0.01% | 259 |
|
|
2023
Q1 | $1.81K | Buy |
2,550
+700
| +38% | +$497 | ﹤0.01% | 303 |
|
|
2022
Q4 | $4.92K | Hold |
1,850
| – | – | ﹤0.01% | 240 |
|
|
2022
Q3 | $7K | Buy |
1,850
+200
| +12% | +$757 | ﹤0.01% | 236 |
|
|
2022
Q2 | $5K | Hold |
1,650
| – | – | ﹤0.01% | 240 |
|
|
2022
Q1 | $7K | Hold |
1,650
| – | – | ﹤0.01% | 245 |
|
|
2021
Q4 | $16K | Sell |
1,650
-1,300
| -44% | -$12.6K | ﹤0.01% | 220 |
|
|
2021
Q3 | $50K | Hold |
2,950
| – | – | 0.02% | 153 |
|
|
2021
Q2 | $82K | Sell |
2,950
-400
| -12% | -$11.1K | 0.02% | 135 |
|
|
2021
Q1 | $75K | Hold |
3,350
| – | – | 0.02% | 134 |
|
|
2020
Q4 | $49K | Buy |
+3,350
| New | +$49K | 0.02% | 131 |
|
|
2020
Q3 | – | Sell |
-3,750
| Closed | -$77K | – | 216 |
|
|
2020
Q2 | $77K | Hold |
3,750
| – | – | 0.03% | 84 |
|
|
2020
Q1 | $71K | Sell |
3,750
-15
| -0.4% | -$284 | 0.05% | 83 |
|
|
2019
Q4 | $108K | Sell |
3,765
-837
| -18% | -$24K | 0.04% | 90 |
|
|
2019
Q3 | $235K | Hold |
4,602
| – | – | 0.12% | 50 |
|
|
2019
Q2 | $364K | Buy |
4,602
+10
| +0.2% | +$791 | 0.2% | 46 |
|
|
2019
Q1 | $303K | Buy |
4,592
+1,865
| +68% | +$123K | 0.21% | 42 |
|
|
2018
Q4 | $151K | Buy |
2,727
+734
| +37% | +$40.6K | 0.11% | 59 |
|
|
2018
Q3 | $180K | Buy |
1,993
+120
| +6% | +$10.8K | 0.09% | 53 |
|
|
2018
Q2 | $177K | Buy |
+1,873
| New | +$177K | 0.08% | 59 |
|